What is the price-to-earnings ratio of Nicox?
The price-earnings ratio of Nicox is currently -1.07.
Nicox P/E 2024
Nicox P/E
-1.07
Ticker
ALCOX.PA
ISIN
FR0013018124
WKN
A143G8
As of Oct 12, 2024, Nicox's P/E ratio was -1.07, a -20.15% change from the -1.34 P/E ratio recorded in the previous year.
The Nicox P/E history
Nicox Aktienanalyse
What does Nicox do?
Nicox SA is a French pharmaceutical company specializing in the development and commercialization of innovative therapy systems for eye diseases. It was founded in 1996 as a spin-off of Nestlé's research activities in the field of ophthalmology. The company's business model is based on the development of drugs based on nitric oxide (NO), a gaseous molecule that plays an important role in regulating blood flow and inflammation processes in the human body. Nicox SA's technology allows for the targeted release of NO donors in specific areas of the eye to reduce disease-related inflammation and damage. This provides a promising alternative to conventional therapies for a range of eye diseases. Nicox SA is divided into three business areas: Ophthalmology, Diagnostics, and Contracts. In the Ophthalmology segment, the company focuses on the development of drugs for the treatment of glaucoma, dry eye, and other eye diseases. Important products in this area include Vyzulta, a combination of an NO donor and a glaucoma drug, as well as NCX 470, an NO donor for the treatment of glaucoma. In addition, the company is working on the development of NCX 4251, an NO donor for the treatment of blepharitis, an inflammation of the eyelids. In the Diagnostics segment, Nicox SA offers innovative diagnostic tests for ophthalmology based on tear fluid analysis. These tests enable ophthalmologists to diagnose and monitor certain eye diseases more quickly and accurately. Key products in this area include AdenoPlus, a rapid test for diagnosing adenovirus conjunctivitis, and ClearSight, a test for monitoring glaucoma patients. The Contracts segment offers customized clinical research services for customers in the pharmaceutical industry. This segment is an important part of Nicox SA's strategy to generate additional revenue and finance the development of new therapies. Overall, Nicox SA has a strong pipeline of new therapies and diagnostic tests that allow the company to consolidate its position as a leading provider of eye medications. The company works closely with its industry and academic research partners to develop and bring innovative therapies to the market. In summary, Nicox SA is an innovative and rapidly growing company focusing on the development and commercialization of therapies for eye diseases. The company has a strong pipeline of new products and services and collaborates closely with its partners to strengthen its position in the industry. Nicox ist eines der beliebtesten Unternehmen auf Eulerpool.com.P/E Details
Deciphering Nicox's P/E Ratio
The Price to Earnings (P/E) Ratio of Nicox is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.
Year-to-Year Comparison
Assessing Nicox's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.
Impact on Investments
The P/E ratio of Nicox is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.
Interpreting P/E Ratio Fluctuations
Fluctuations in Nicox’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.
Frequently Asked Questions about Nicox stock
How has the price-earnings ratio of Nicox changed compared to last year?
The price-to-earnings ratio of Nicox has increased by -20.15% fallen (meaning "decreased" or "dropped") compared to last year.
What consequences does a high price-earnings ratio have for investors?
A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.
What does a low price-earnings ratio mean?
A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.
Is the price-earnings ratio of Nicox high compared to other companies?
Yes, the price-to-earnings ratio of Nicox is high compared to other companies.
How does an increase in the price-earnings ratio of Nicox affect the company?
An increase in the price-earnings ratio of Nicox would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.
How does a reduction in the price-to-earnings ratio of Nicox affect the company?
A decrease in the price-earnings ratio of Nicox would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.
What are some factors that influence the price-earnings ratio of Nicox?
Some factors that influence the price-earnings ratio of Nicox are the company's growth, financial position, industry development, and the overall economic situation.
How much dividend does Nicox pay?
Over the past 12 months, Nicox paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Nicox is expected to pay a dividend of 0 EUR.
What is the dividend yield of Nicox?
The current dividend yield of Nicox is .
When does Nicox pay dividends?
Nicox pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Nicox?
Nicox paid dividends every year for the past 0 years.
What is the dividend of Nicox?
For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.
In which sector is Nicox located?
Nicox is assigned to the 'Health' sector.
Wann musste ich die Aktien von Nicox kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Nicox from 10/12/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 10/12/2024.
When did Nicox pay the last dividend?
The last dividend was paid out on 10/12/2024.
What was the dividend of Nicox in the year 2023?
In the year 2023, Nicox distributed 0 EUR as dividends.
In which currency does Nicox pay out the dividend?
The dividends of Nicox are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Nicox stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Nicox
Our stock analysis for Nicox Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Nicox Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.